Home
Home

Amira

Bristol-Myers Takes Over Amira Pharma

Bristol-Myers Takes Over Amira Pharma
Yahoo/Zacks.com

Bristol-Myers' Acquisition Could Pay for Itself

Bristol-Myers' Acquisition Could Pay for Itself
Motley Fool

Bristol-Myers Acquires Amira Pharmaceuticals, Scoops Up Lung Drug

Bristol-Myers Acquires Amira Pharmaceuticals, Scoops Up Lung Drug
Motley Fool

Drugmaker Bristol-Myers acquires Amira Pharma in deal that could be worth $475 million

Drugmaker Bristol-Myers acquires Amira Pharma in deal that could be worth $475 million
Yahoo/AP

Amira Pharmaceuticals to Present Preclinical Data on AM152 , an LPA1 Receptor Antagonist, at the Annual Meeting of the American Thoracic Society

Amira Pharmaceuticals to Present Preclinical Data on AM152 , an LPA1 Receptor Antagonist, at the Annual Meeting of the American Thoracic Society
PR-USA.net

News

Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amira's Lead DP2 Antagonist, AM211
Pipeline Review
»